The Zacks Analyst Blog Highlights Toyota Motor, AstraZeneca, Chubb, Air T and Preformed Line Products Toyota Motor, AstraZeneca, Chubb, Air T and Preformed Line Products are part of the Zacks top Analyst Blog.…
Tagrisso US approval in unresectable lung cancer 26 September 2024 Tagrisso approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer Based on LAURA Phase III trial results which showed Tagrisso extended…
Buy These 5 Big Drug Stocks to Boost Your Portfolios Health Pfizer, Eli Lilly, AstraZeneca, Bayer and Sanofi can prove to be great additions to your portfolio.…
AZNs Tagrisso Gets FDA Nod for Expanded Use in NSCLC The FDA approves AstraZenecas Tagrisso for treating unresectable, stage III EGFR-mutated non-small cell lung cancer.…
AstraZeneca Stock Up Almost 14% in 6 Months: Time to Buy? AZNs key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga are likely to drive sales. It has several candidates with…